These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW. Cancer Res; 1988 Jul 15; 48(14):4107-12. PubMed ID: 3164256 [Abstract] [Full Text] [Related]
8. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA]. Okamura Y, Takatsuka Y, Katoh T, Tsumura I, Kobayakawa K, Kawahara T. Gan To Kagaku Ryoho; 1991 Jul 15; 18(8):1279-85. PubMed ID: 2069399 [Abstract] [Full Text] [Related]
10. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA]. Komuro K, Watanabe K, Ishida T, Sakurai M, Amano R, Hagiwara H, Hara Y, Hanzawa T, Itsubo K. Gan To Kagaku Ryoho; 1986 Oct 15; 13(11):3145-9. PubMed ID: 3465273 [Abstract] [Full Text] [Related]
12. [CA15-3 tumor marker in early detection of breast cancer]. Roisman I, Shiloni E, Lifshiz I, Shoshani D, Saphir D, Honigman I, Livni N, Sherman Y, Papo O, Durst AL. Harefuah; 1992 Feb 16; 122(4):213-8. PubMed ID: 1563679 [Abstract] [Full Text] [Related]
14. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients. Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H. Jpn J Clin Oncol; 2006 Mar 16; 36(3):150-3. PubMed ID: 16520359 [Abstract] [Full Text] [Related]
18. [Tumor markers in human breast cancer]. Takami H, Shikata J. Gan To Kagaku Ryoho; 1987 Nov 16; 14(11):2998-3003. PubMed ID: 3479050 [Abstract] [Full Text] [Related]